These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2799766)

  • 1. Desmopressin induces decrease in platelet serotonin content in uremia.
    Małyszko J; Pietraszek MH; Azzadin A; Buczko W; Myśliwiec M
    Thromb Haemost; 1989 Jun; 61(3):537. PubMed ID: 2799766
    [No Abstract]   [Full Text] [Related]  

  • 2. A partial role of serotonin in normalization of the bleeding time by DDAVP in uraemic rats.
    Pietraszek M; Azzadin A; Buczko W; Malyszko J; Mysliwiec M
    Thromb Haemost; 1992 Nov; 68(5):625. PubMed ID: 1455414
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possible role of serotonin in hemostatic the mechanism of action of desmopressin (DDAVP) in patients with uremia].
    Małyszko J; Małyszko J; Pietraszek M; Azzadin A; Myśliwiec M; Buczko W
    Pol Arch Med Wewn; 1993 Aug; 90(2):105-11. PubMed ID: 8247943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients.
    Malyszko J; Malyszko JS; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1992 Nov; 68(3):303-8. PubMed ID: 1471076
    [No Abstract]   [Full Text] [Related]  

  • 5. Desmopressin induces decrease in platelet count in uremia.
    Rydzewski A; Rowiński M; Myśliwiec M
    Thromb Haemost; 1986 Jun; 55(3):436. PubMed ID: 3750273
    [No Abstract]   [Full Text] [Related]  

  • 6. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients.
    Lee HK; Kim YJ; Jeong JU; Park JS; Chi HS; Kim SB
    Nephron Clin Pract; 2010; 114(4):c248-52. PubMed ID: 20090366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
    Alarcón F; Mezzano D; Vial S; Pereira J
    Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558
    [No Abstract]   [Full Text] [Related]  

  • 8. Desmopressin (d-DAVP) effects on platelet rheology and von Willebrand factor activities in uremia.
    Zeigler ZR; Megaludis A; Fraley DS
    Am J Hematol; 1992 Feb; 39(2):90-5. PubMed ID: 1550112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease.
    Gordz S; Mrowietz C; Pindur G; Park JW; Jung F
    Clin Hemorheol Microcirc; 2005; 32(2):83-7. PubMed ID: 15764817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
    Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
    Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of desmopressin on protein S and antithrombin III in uremia.
    Akpolat T; Eser M; Albayrak D; Arik N
    Nephron; 1997; 77(3):362. PubMed ID: 9375836
    [No Abstract]   [Full Text] [Related]  

  • 12. Desmopressin and super platelets.
    Pecci A; Balduini CL
    Blood; 2014 Mar; 123(12):1779-80. PubMed ID: 24652962
    [No Abstract]   [Full Text] [Related]  

  • 13. Desmopressin stimulates the expression of P-selectin on human platelets in vitro.
    Wun T; Paglieroni TG; Lachant NA
    J Lab Clin Med; 1995 Oct; 126(4):401-9. PubMed ID: 7561450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia.
    Akpolat T; Ozdemir O; Arik N; Demirkan F; Sungur C; Ozcebe O; Dündar S; Yasavul U; Turgan C; Kirazli S
    Nephron; 1993; 64(2):232-4. PubMed ID: 8321356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy.
    Ranucci M; Nano G; Pazzaglia A; Bianchi P; Casana R; Tealdi DG
    J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):851-4. PubMed ID: 18068065
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo effects of desmopressin on platelet function.
    Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
    Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products.
    D'Angelo A; Capitanio A; Smith JB; Valsecchi C; Mannucci PM
    Thromb Haemost; 1983 Feb; 49(1):64-5. PubMed ID: 6687766
    [No Abstract]   [Full Text] [Related]  

  • 18. Conjugated estrogens shorten bleeding time in uraemia: a possible role of serotonin?
    Malyszko JS; Malyszko J; Azzadin A; Buczko W; Mysliwiec M
    Thromb Haemost; 1995 Jan; 73(1):164-5. PubMed ID: 7740490
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet and plasma serotonin concentrations in glomerulonephritis, II.
    Parbtani A; Frampton G; Cameron JS
    Clin Nephrol; 1980 Sep; 14(3):112-23. PubMed ID: 7418277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced response of uraemic bleeding time to repeated doses of desmopressin.
    Canavese C; Salomone M; Pacitti A; Mangiarotti G; Calitri V
    Lancet; 1985 Apr; 1(8433):867-8. PubMed ID: 2858723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.